3 days popular7 days popular1 month popular3 months popular

Results from the largest published international study to investigate treatment to reduce recurrence of blood clots in cancer patients

Results of the landmark CATCH (Comparison of Acute Treatments in Cancer Haemostasis) study were published on the 18th August in The Journal of American Medical Association (JAMA), comparing innohep® (tinzaparin), a low-molecular weight heparin (LMWH), with warfarin in patients with cancer associated thrombosis (CAT). In the study, sponsored by LEO Pharma, the six-month incidence of [...]

Study: Abdominal blood clots may indicate undiagnosed cancer

New research published online in Blood, the Journal of the American Society of Hematology (ASH), concludes that a blood clot in an abdominal vein may be an indicator of undiagnosed cancer. The study also suggests that these clots predict poorer survival in patients with liver and pancreatic cancer. Compared to the general population, individuals who [...]

Comparison of blood clot treatments illuminate recurrence risk in high-risk groups

Studies presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition compare new and standard-of-care treatments for blood clots and further illuminate clot risks in vulnerable populations, such as cancer patients. Although significant advances have been made in the treatment and prevention of blood clots through new and improved therapies for clotting [...]

Protein in plasma may one day change transfusions

In injured mice, the naturally occurring protein fibronectin is instrumental in stopping bleeding but interestingly also at preventing life-threatening blood clots – according to new research published in Journal of Clinical Investigation. When someone is bleeding, a blood clot is a positive response – the body forms the clot as a plug to stop bleeding. [...]

When warfarin cannot be used, aspirin may reduce the risks of reoccurring blood clots

Aspirin may be a promising alternative for those who can’t take long-term anticoagulant drugs that prevent clots from reoccurring in the veins, according to new research in the American Heart Association journal Circulation. In a combined analysis of two similar independent studies, 1,224 patients who received 100 mg of aspirin a day to treat blood [...]